Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats (Q43764314)

26 November 2017

title

Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats (English)

1 reference

26 November 2017

1 reference

1 reference

de Mello CF

1 reference

26 November 2017

Kölker S

1 reference

26 November 2017

Ahlemeyer B

1 reference

26 November 2017

de Souza FR

1 reference

26 November 2017

Fighera MR

1 reference

26 November 2017

Mayatepek E

1 reference

26 November 2017

Krieglstein J

1 reference

26 November 2017

Hoffmann GF

1 reference

26 November 2017

Wajner M

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

1 reference

inferred from page(s)

published in

Brain Research

1 reference

26 November 2017

volume

916

1 reference

26 November 2017

issue

1-2

1 reference

26 November 2017

page(s)

70-75

1 reference

Diagnosis and management of glutaric aciduria type I.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Age at symptom onset predicts severity of motor impairment and clinical outcome of glutaric acidemia type 1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Ionic dependence of glutamate neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Neuroprotection by Estrogens in a Mouse Model of Focal Cerebral Ischemia and in Cultured Neurons: Evidence for a Receptor-Independent Antioxidative Mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Intrastriatal methylmalonic acid administration induces rotational behavior and convulsions through glutamatergic mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Excitatory amino acid receptors in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Glutaric aciduria: biochemical and morphologic considerations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Glutaryl-CoA dehydrogenase mutations in glutaric acidemia (type I): review and report of thirty novel mutations

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Assignment of human glutaryl-CoA dehydrogenase gene (GCDH) to the short arm of chromosome 19 (19p13.2) by in situ hybridization and somatic cell hybrid analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Neurological manifestations of organic acid disorders

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Cerebral organic acid disorders induce neuronal damage via excitotoxic organic acids in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Evaluation of trigger factors of acute encephalopathy in glutaric aciduria type I: fever and tumour necrosis factor-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Potentiation of 3-hydroxyglutarate neurotoxicity following induction of astrocytic iNOS in neonatal rat hippocampal cultures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Glutaric aciduria type 1 an atypical presentation together with some observations upon treatment and the possible cause of cerebral damage

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Biochemistry of glutaric aciduria type I: activities of in vitro expressed wild-type and mutant cDNA encoding human glutaryl-CoA dehydrogenase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Excitatory amino acids as a final common pathway for neurologic disorders.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Neurotransmission in epilepsy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Anticonvulsant activity of the NMDA antagonists, D(-)4-(3-phosphonopropyl) piperazine-2-carboxylic acid (D-CPP) and D(-)(E)-4-(3-phosphonoprop-2-enyl) piperazine-2-carboxylic acid (D-CPPene) in a rodent and a primate model of reflex epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Inhibition of synaptosomal [3H]glutamate uptake and [3H]glutamate binding to plasma membranes from brain of young rats by glutaric acid in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Inhibitory, GABAergic Nerve Terminals Decrease at Sites of Focal Epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

In-vivo demonstration of reduced benzodiazepine receptor binding in human epileptic foci

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Inhibition of brain glutamate decarboxylase by glutarate, glutaconate, and β-Hydroxyglutarate: Explanation of the symptoms in glutaric aciduria?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Glutaric aciduria type I: pathomechanisms of neurodegeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Mutation analysis in glutaric aciduria type I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

Glutamate receptors in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2801%2902865-7

10.1016/S0006-8993(01)02865-7

7 January 2021

Identifiers

DOI

1 reference

26 November 2017

1 reference